Genesee Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Hold |
13,364
| – | – | 0.1% | 109 |
|
|
2025
Q1 | $205K | Sell |
13,364
-1,664
| -11% | -$25.6K | 0.1% | 111 |
|
|
2024
Q4 | $331K | Buy |
15,028
+1,664
| +12% | +$36.7K | 0.15% | 98 |
|
|
2024
Q3 | $241K | Hold |
13,364
| – | – | 0.12% | 110 |
|
|
2024
Q2 | $217K | Hold |
13,364
| – | – | 0.11% | 110 |
|
|
2024
Q1 | $189K | Hold |
13,364
| – | – | 0.1% | 115 |
|
|
2023
Q4 | $140K | Hold |
13,364
| – | – | 0.09% | 108 |
|
|
2023
Q3 | $136K | Hold |
13,364
| – | – | 0.1% | 89 |
|
|
2023
Q2 | $101K | Hold |
13,364
| – | – | 0.07% | 86 |
|
|
2023
Q1 | $118K | Hold |
13,364
| – | – | 0.08% | 83 |
|
|
2022
Q4 | $122K | Hold |
13,364
| – | – | 0.09% | 75 |
|
|
2022
Q3 | $108K | Hold |
13,364
| – | – | 0.08% | 80 |
|
|
2022
Q2 | $100K | Hold |
13,364
| – | – | 0.07% | 89 |
|
|
2022
Q1 | $125K | Hold |
13,364
| – | – | 0.07% | 104 |
|
|
2021
Q4 | $107K | Buy |
13,364
+1,975
| +17% | +$15.8K | 0.05% | 105 |
|
|
2021
Q3 | $111K | Buy |
+11,389
| New | +$111K | 0.05% | 108 |
|
|
2021
Q2 | – | Sell |
-11,389
| Closed | -$131K | – | 116 |
|
|
2021
Q1 | $131K | Hold |
11,389
| – | – | 0.08% | 87 |
|
|
2020
Q4 | $109K | Hold |
11,389
| – | – | 0.07% | 81 |
|
|
2020
Q3 | $102K | Hold |
11,389
| – | – | 0.08% | 71 |
|
|
2020
Q2 | $140K | Hold |
11,389
| – | – | 0.13% | 68 |
|
|
2020
Q1 | $102K | Buy |
+11,389
| New | +$102K | 0.1% | 73 |
|